EGCG increases p53 acetylation in Lys382, enhancing its stabilization and DNA binding, increases p21 expression, downregulates HDAC-4, -5, and -6, and stimulates apoptotic induction in lung cancer cells (Oya et al., 2017). Here, TP53 is linked to lung cancer.